The evaluation of LPS levels has been used as a marker of inflammation in individuals with T2D due to its clear association with common processes in this disease, such as obesity (increased BMI), glycemic dysregulation—characterized by abnormalities in blood sugar stability and reflected in elevated HbA1c levels—and inflammation (elevated IL-6 and hs-CRP) [42]. This evidence concerns the gene IL6 and type 2 diabetes mellitus.